Family Medicine Doctors in Pelham, AL Accepting Medicare

9 Family Medicine doctors found. Showing 1 - 9

Vasinee Unnoppetchara, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2805 Pelham Pkwy, Pelham, AL 35124 Phone: 205-663-5970    Fax: 205-663-2790

David Eugen Wever, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3170 Pelham Pkwy, Pelham, AL 35124 Phone: 205-620-2270    Fax: 205-620-2279

Dr. Robert Craven Snyder Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2508 Pelham Pkwy, Pelham, AL 35124 Phone: 205-664-0880    Fax: 205-664-0895

Eric S Solomon, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 120 Cahaba Valley Parkway, Suite 200, Pelham, AL 35124 Phone: 205-733-1130    Fax: 205-560-0451

Dr. Thomas James Smitherman Iii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Racquet Club Pkwy, Pelham, AL 35124 Phone: 205-620-1090    Fax: 205-620-1153

Timothy Pattison Taylor Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Big Mountain Road, Pelham, AL 35124 Phone: 205-644-8260    Fax: 205-905-6127

Marie C Pittman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Cahaba Valley Pkwy Ste 203, Pelham, AL 35124 Phone: 205-985-9828    Fax: 205-969-0971

Jason H. Todd, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 30 Racquet Club Parkway, Pelham, AL 35124 Phone: 205-620-1087    Fax: 205-620-1091

Dr. Aubrey Dennis Scott, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3143 Pelham Pkwy, Suite 100, Pelham, AL 35124 Phone: 205-545-9530    Fax: 205-545-9529

News Archive

Novel radiotherapy approach for lung cancer

A novel radiotherapy approach has shown promise as a treatment option, and may possibly increase the cure rate, for people with early stage lung cancer who are unable to tolerate surgery, according to findings from a five-year study led by SUNY Upstate Medical University.

Conference attendees express concern over growing burden of NCDs

Inter Press Service reports on "a conference organized by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on World Cancer Day [February 4] in Geneva," during which experts warned about the growing burden of non-communicable diseases (NCDs) - "cancer, heart disease, diabetes and chronic respiratory diseases, among others" - especially in low- and middle-income countries.

UMass Medical School licenses "anti-gal" technology to Agalimmune

The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.

ReShape Medical initiates IDE clinical study to assess effectiveness of dual-balloon device for weight loss

ReShape Medical™, Inc. announced today that it has initiated a U.S. Investigational Device Exemption (IDE) clinical study to assess the safety and effectiveness of its non-surgical, dual-balloon device for weight loss. The ReShape Balloons are designed to be a treatment for the millions who want support with weight loss, without the invasiveness of surgery.

Read more Medical News

› Verified 8 days ago